Enforcement committee flags underreporting, recommends standardized ADDS QA template and clearer inspection communications

The board's Enforcement & Compounding Committee presented annual summaries of its inspection program and citation activity and reported on the board's review of quality assurance (QA) reports tied to automated drug delivery systems (ADDS).

Inspectors and staff described progress toward the board’s strategic objective of inspecting every licensed pharmacy within a four‑year cycle. Committee members commended inspectors for reaching the goal and requested that next year’s presentation break down inspection data by license type, and include plain language definitions (for example, “order of correction” vs. “written notice”) attached to inspection reports so licensees clearly understand outcomes and next steps.

The committee also reviewed citation trends and noted a decline in…